About Contact
Friday, July 3, 2026
News

IFC’s Immunity Paradox


MDB Accountability  ·  Sovereign Immunity  ·  IFC  ·  MDB Reform Platform

The Immunity Paradox: How IFC Cannot Be Sovereign and Commercial Simultaneously

Why Cambodia has put the commercial activity question back before the courts — and why IFC’s own Board determination makes it impossible to answer in IFC’s favour.

IFC in US Federal Courts
Claims sovereign immunity
IFC’s lending and investment activities are governmental in character — not commercial. The FSIA commercial activity exception does not apply. Communities harmed by IFC-backed projects cannot sue in US federal courts.
VERSUS
IFC Before Its Own Watchdog
Claims commercial distance
IFC’s investments in Cambodian microfinance lenders are commercial investments in private intermediaries. It is one step removed from end borrowers. Its E&S obligations do not extend to downstream harm. (IFC Board, June 23, 2026)

Full Analytical Note (PDF) — The Immunity Paradox: How IFC Cannot Be Sovereign and Commercial Simultaneously
Six sections: what Jam v. IFC decided and did not decide, why financial intermediary activity is commercial under FSIA, the Board’s June 23 decision as US-based conduct, the binary IFC cannot escape, and the Double Void that results.

↓  Download Full Note (PDF)

What Jam v. IFC Actually Decided — And Did Not Decide

The Supreme Court’s 2019 ruling in Jam v. IFC removed near-absolute immunity for international organisations. It established that MDBs share the same restrictive immunity as foreign governments under the FSIA: immune for sovereign acts, not immune for commercial acts. What it did not do is rule that IFC’s lending is commercial activity. Chief Justice Roberts’ caution — that “it should not be assumed that the lending activity of development banks qualifies as commercial activity” — was obiter dictum, not a holding. No court has ruled on this. The question is open.

On remand, the DC Circuit sidestepped the commercial activity question entirely. The Gujarati fishermen’s lawsuit was “based upon” CGPL’s Indian operations — not IFC’s Washington lending decisions. The Supreme Court declined to hear the case again in 2022. Near-absolute immunity survived under a different theory. The fishermen received nothing. Seven years. Nothing.

IssueStatus after Jam and remand
Is MDB immunity near-absolute?No — Supreme Court (2019): same restrictive immunity as foreign governments under FSIA
Is IFC’s financial intermediary activity “commercial” under FSIA?Not decided — DC Circuit (2021) sidestepped; Roberts caveat was obiter dictum, not a holding
Can a claim based on IFC’s own Washington decision satisfy “based upon”?Not decided — Jam was based on a third party’s Indian operations; the Cambodia Board decision is a different factual structure
Has IFC waived immunity through its Articles?No waiver found — DC Circuit (2021); Supreme Court denied cert (2022)

Sources: Jam v. IFC, 586 U.S. (2019); DC Circuit No. 20-7097 (July 6, 2021).

Why Financial Intermediary Activity Is Commercial

IFC held equity positions and loan exposures in ACLEDA, Amret, Prasac, Hattha Bank, LOLC, and Sathapana — private, for-profit Cambodian banks, incorporated under Cambodian company law, charging commercial interest rates, reporting profits to shareholders. IFC invested to earn returns. It received dividends and interest. It exercised shareholder rights. No sovereign authority is required to hold equity in a private bank. A private equity fund performs the same acts daily. These are commercial acts in the FSIA sense.

IFC’s own June 23, 2026 Board determination stated IFC is “a commercial investor one step removed from end borrowers.” That characterisation is, on its face, an argument that IFC engages in commercial activity under the FSIA. IFC’s lawyers wrote those words. The Board adopted them. They are now in the primary record — and they undermine the immunity claim IFC makes in every US courtroom.

The Board’s June 23 Decision as US-Based Conduct

The DC Circuit’s escape route in the Gujarat case — that the lawsuit was “based upon” CGPL’s Indian operations, not IFC’s Washington lending — is not available for a claim based on the IFC Board’s June 23, 2026 decision. That decision was made in Washington DC, by IFC’s governing body, at IFC’s headquarters. It is IFC’s own direct conduct — a Board vote to deny remedy to 18 complainants whose harm an independent investigation found was connected to IFC’s policy noncompliance.

The Gujarati fishermen’s claim was based upon what CGPL did in Gujarat. A Cambodian complainant’s claim would be based upon what the IFC Board did in Washington. These are materially different factual structures.

The Binary IFC Cannot Escape

IFC must bear the obligations sovereign actors bear. Citizens can access accountability mechanisms. Independent watchdog findings bind the institution. The Board cannot override the CAO.

Accept citizen-facing accountability

If IFC’s activities are commercial —

The FSIA commercial activity exception applies and sovereign immunity fails. Commercial actors are not immune from suit in their country of domicile.

Accept judicial accountability

IFC must choose. Cambodia has made the dual position explicit in a single Board determination — the same document that constructs the accountability escape simultaneously undermines the immunity claim. Both shields are invoked in the same case, on the same investments, on the same day. Both cannot hold.

The Double Void

The Double Void: What Results When Both Shields Hold

The CAO investigated for four years. The Board overrode the findings. Internal accountability: neutralised. The Gujarati communities litigated for seven years. The DC Circuit dismissed. Judicial accountability: blocked.

The Double Void is not a theoretical construct. It is a documented institutional reality, confirmed in two separate cases involving different instruments, different countries, and different categories of harm. One Cambodian complainant died while the investigation was underway. The void is not abstract.

The question is no longer whether MDB accountability has gaps. Cambodia raises the more fundamental question of whether an institution that claims sovereign immunity in court and commercial distance in governance is accountable to any independent body at all.

📄
Full Analytical Note (PDF) — The Immunity Paradox
Includes the complete legal analysis, reform implications for the new IAM, and the path back to US courts.

↓  Download Full Note (PDF)

Related Analysis


Analysis

Kofi and the Cruise Ship

MDB Results 2026: An Independent Assessment — Series Introduction A Story for Children of All Ages By Parminder…

March 24, 2026PBrar

News

The Full Picture

MDB Results 2026: An Independent Assessment — Day 7 of 7 The Full Picture By Parminder Brar  | …

March 31, 2026PBrar

Browse by Topic